OBJECTIVE: To investigate the association between alcohol consumption and type 2 diabetes, and determine whether this is modified by sex, body mass index (BMI) and beverage type. DESIGN: Multicentre prospective case-cohort study. SETTING: Eight countries from the European Prospective Investigation into Cancer and Nutrition cohort. SUBJECTS: A representative baseline sample of 16 154 participants and 12 403 incident cases of type 2 diabetes. INTERVENTIONS: Alcohol consumption assessed using validated dietary questionnaires. MAIN OUTCOME MEASURES: Occurrence of type 2 diabetes based on multiple sources (mainly self-reports), verified against medical information. RESULTS: Amongst men, moderate alcohol consumption was nonsignificantly associated with a lower incidence of diabetes with a hazard ratio (HR) of 0.90 (95% CI: 0.78-1.05) for 6.1-12.0 versus 0.1-6.0 g day(-1) , adjusted for dietary and diabetes risk factors. However, the lowest risk was observed at higher intakes of 24.1-96.0 g day(-1) with an HR of 0.86 (95% CI: 0.75-0.98). Amongst women, moderate alcohol consumption was associated with a lower incidence of diabetes with a hazard ratio of 0.82 (95% CI: 0.72-0.92) for 6.1-12.0 g day(-1) (P interaction gender <0.01). The inverse association between alcohol consumption and diabetes was more pronounced amongst overweight (BMI ≥ 25 kg m(-2) ) than normal-weight men and women (P interaction < 0.05). Adjusting for waist and hip circumference did not alter the results for men, but attenuated the association for women (HR=0.90, 95% CI: 0.79-1.03 for 6.1-12.0 g day(-1) ). Wine consumption for men and fortified wine consumption for women were most strongly associated with a reduced risk of diabetes. CONCLUSIONS: The results of this study show that moderate alcohol consumption is associated with a lower risk of type 2 diabetes amongst women only. However, this risk reduction is in part explained by fat distribution. The relation between alcohol consumption and type 2 diabetes was stronger for overweight than normal-weight women and men.
OBJECTIVE: To investigate the association between alcohol consumption and type 2 diabetes, and determine whether this is modified by sex, body mass index (BMI) and beverage type. DESIGN: Multicentre prospective case-cohort study. SETTING: Eight countries from the European Prospective Investigation into Cancer and Nutrition cohort. SUBJECTS: A representative baseline sample of 16 154 participants and 12 403 incident cases of type 2 diabetes. INTERVENTIONS: Alcohol consumption assessed using validated dietary questionnaires. MAIN OUTCOME MEASURES: Occurrence of type 2 diabetes based on multiple sources (mainly self-reports), verified against medical information. RESULTS: Amongst men, moderate alcohol consumption was nonsignificantly associated with a lower incidence of diabetes with a hazard ratio (HR) of 0.90 (95% CI: 0.78-1.05) for 6.1-12.0 versus 0.1-6.0 g day(-1) , adjusted for dietary and diabetes risk factors. However, the lowest risk was observed at higher intakes of 24.1-96.0 g day(-1) with an HR of 0.86 (95% CI: 0.75-0.98). Amongst women, moderate alcohol consumption was associated with a lower incidence of diabetes with a hazard ratio of 0.82 (95% CI: 0.72-0.92) for 6.1-12.0 g day(-1) (P interaction gender <0.01). The inverse association between alcohol consumption and diabetes was more pronounced amongst overweight (BMI ≥ 25 kg m(-2) ) than normal-weight men and women (P interaction < 0.05). Adjusting for waist and hip circumference did not alter the results for men, but attenuated the association for women (HR=0.90, 95% CI: 0.79-1.03 for 6.1-12.0 g day(-1) ). Wine consumption for men and fortified wine consumption for women were most strongly associated with a reduced risk of diabetes. CONCLUSIONS: The results of this study show that moderate alcohol consumption is associated with a lower risk of type 2 diabetes amongst women only. However, this risk reduction is in part explained by fat distribution. The relation between alcohol consumption and type 2 diabetes was stronger for overweight than normal-weight women and men.
Authors: William C Kerr; Edwina Williams; Libo Li; Camillia K Lui; Yu Ye; Thomas K Greenfield; E Anne Lown Journal: Prev Med Date: 2018-02-03 Impact factor: 4.018
Authors: William C Kerr; Yu Ye; Edwina Williams; Camillia K Lui; Thomas K Greenfield; E Anne Lown Journal: Alcohol Clin Exp Res Date: 2018-12-10 Impact factor: 3.455
Authors: Franziska Jannasch; Janine Kröger; Claudia Agnoli; Aurelio Barricarte; Heiner Boeing; Valerie Cayssials; Sandra Colorado-Yohar; Christina C Dahm; Courtney Dow; Guy Fagherazzi; Paul W Franks; Heinz Freisling; Marc J Gunter; Nicola D Kerrison; Timothy J Key; Kay-Tee Khaw; Tilman Kühn; Cecilie Kyro; Francesca Romana Mancini; Olatz Mokoroa; Peter Nilsson; Kim Overvad; Domenico Palli; Salvatore Panico; Jose Ramón Quirós García; Olov Rolandsson; Carlotta Sacerdote; Mariá-José Sánchez; Mohammad Sediq Sahrai; Ruth Schübel; Ivonne Sluijs; Annemieke M W Spijkerman; Anne Tjonneland; Tammy Y N Tong; Rosario Tumino; Elio Riboli; Claudia Langenberg; Stephen J Sharp; Nita G Forouhi; Matthias B Schulze; Nicholas J Wareham Journal: J Nutr Date: 2019-06-01 Impact factor: 4.798
Authors: Darren R Brenner; Tiffany R Haig; Abbey E Poirier; Alianu Akawung; Christine M Friedenreich; Paula J Robson Journal: Health Promot Chronic Dis Prev Can Date: 2017-12 Impact factor: 3.240
Authors: F Bonnet; E Disse; M Laville; A Mari; K Hojlund; C H Anderwald; P Piatti; B Balkau Journal: Diabetologia Date: 2012-08-31 Impact factor: 10.122
Authors: Fumiaki Imamura; Matthias B Schulze; Stephen J Sharp; Marcela Guevara; Dora Romaguera; Benedetta Bendinelli; Elena Salamanca-Fernández; Eva Ardanaz; Larraitz Arriola; Dagfinn Aune; Heiner Boeing; Courtney Dow; Guy Fagherazzi; Paul W Franks; Heinz Freisling; Paula Jakszyn; Rudolf Kaaks; Kay-Tee Khaw; Tilman Kühn; Francesca R Mancini; Giovanna Masala; Maria-Dolores Chirlaque; Peter M Nilsson; Kim Overvad; Valeria M Pala; Salvatore Panico; Aurora Perez-Cornago; Jose R Quirós; Fulvio Ricceri; Miguel Rodríguez-Barranco; Olov Rolandsson; Ivonne Sluijs; Magdalena Stepien; Annemieke M W Spijkerman; Anne Tjønneland; Tammy Y N Tong; Rosario Tumino; Linda E T Vissers; Heather A Ward; Claudia Langenberg; Elio Riboli; Nita G Forouhi; Nick J Wareham Journal: J Nutr Date: 2019-11-01 Impact factor: 4.798
Authors: Patricia E Molina; Angela M Amedee; Peter Winsauer; Steve Nelson; Gregory Bagby; Liz Simon Journal: J Neuroimmune Pharmacol Date: 2015-03-21 Impact factor: 4.147